Nico Van Tichelen, VIPUN Medical CEO: “We thank EIT Health for this recognition as medical device start-up with promising technology and look forward to executing the awarded project. The project, which entails patent strategy evaluation, as well as clinical, regulatory, health economic analysis and planning, has a total value of € 62,500 and will be executed before December 31st, 2019.
The VIPUN Gastric Monitoring System (GMS) provides, for the first time, and in an easy and affordable manner, insight into the stomach function of a patient and can either be used as a continuous monitoring tool (e.g. in ICU patients with feeding intolerance) or for stomach motility diagnostics (e.g. in Diabetic Gastroparesis patients).